Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2016 > Volume 25 Number 3 May 2016 > MITRAL VALVE DISEASE > Treatment of Mitral Valve Regurgitation with an Open Rigid Annuloplasty Ring

Treatment of Mitral Valve Regurgitation with an Open Rigid Annuloplasty Ring

Clement Venner1,4, Olivier Huttin1, Antonio Fiore2,3, Cristina Sirbu2, Jean-Pierre Villemot2,3, Juan-Pablo Maureira2,3

1Department of Cardiology, University Hospital of Nancy, Vandoeuvre les Nancy, France
2Department of Cardiac Surgery, University Hospital of Nancy, Vandoeuvre les Nancy, France
3School of Surgery, University of Lorraine, Vandoeuvre les Nancy, France
4Electronic correspondence: c.venner@chru-nancy.fr

Background and aim of the study: Annuloplasty constitutes a major operative step in the surgical treatment of degenerative mitral valve regurgitation (MR). The choice of ring structure to obtain an adequate remodeling of the mitral orifice and to respect the motion of the mitral apparatus remains the subject of debate. The study aim was to determine the clinical and echocardiographic outcome when using an open rigid ring to treat MR.

Methods: A total of 129 patients (94 men, 35 women; mean age 64.5 ± 11.7 years) was referred to the authors’ institution between 1997 and 2011 for the surgical management of severe MR. Patients were implanted with a modified open rigid annuloplasty ring, and also underwent anterior and/or posterior leaflet repair. The occurrence of any major adverse cardiac and cerebrovascular event (MACCE) was considered as the primary end-point and was retrospectively collected along with echocardiographic data.


Results: The perioperative mortality was 1.6%. The cardiopulmonary bypass and cross-clamp times were 73.3 ± 17.1 min and 51.6 ± 13.0 min, respectively. There was one case (0.7%) of postoperative mitral systolic anterior motion. During a mean follow up period of 6.0 ± 3.1 years, 25 patients (19%) presented a MACCE. MACCE-free survival at one, five and 10 years was respectively 96.8%, 91.3%, and 61.4%. Preoperative determinants of MACCE were paroxysmal/persistent atrial fibrillation (HR 2.53; 95% CI: 1.06-6.01; p = 0.035) and age (HR 1.05; 95% CI: 1-1.09; p = 0.035).

Conclusion: Mitral valve repair with an open-rigid ring offers satisfactory long-term results with a low rate of subsequent MR recurrence and reintervention. Preoperative AF is the main determinant of long-term adverse outcome.

The Journal of Heart Valve Disease 2016;25:332-340


Treatment of Mitral Valve Regurgitation with an Open Rigid Annuloplasty Ring

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.